Generate a tailored SOP for Dr. Farzana Pashankar. Improve your application with a focused, well-structured draft.
Farzana Pashankar is a distinguished pediatric hematologist-oncologist specializing in the treatment of children with sickle cell disease and solid tumors. An international expert on germ cell tumors and rare tumors, Dr. Pashankar's research focuses on clinical trial development, having chaired and contributed to various international projects. She is the Director of the Pediatric Solid Tumor Program and the Pediatric Hematology Oncology Fellowship Program at Yale School of Medicine. Dr. Pashankar completed her education at the University of Pune in India, continuing her training in the UK before completing her residency and fellowship in the United States. Her work has led to significant improvements in the understanding and treatment of pediatric hematological conditions. She is especially known for her innovative research on hydroxyurea treatment's effects on pulmonary hypertension in children with sickle cell disease. Through various clinical trials, she seeks to broaden the treatment options and improve the quality of life for children facing these challenging health conditions.
Yale School of Medicine • New Haven, CT
Dr. Pashankar leads various research and clinical programs focusing on pediatric hematology and oncology.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.